日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond

预测原发性血小板增多症预后的实用工具：AAA风险模型及其他

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025017896
Sönmez, Özge; Oyur, Esiyla; Yönal Hindilerden, İpek; Hindilerden, Fehmi; Sönmez, Mehmet; Karışmaz, Abdülkadir; Atlı, Zeynep; Soysal, Teoman; Eşkazan, Ahmet Emre
血小板
发表日期：2026
文献求助 收藏

Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT

移植预处理强度（TCI）评分可预测骨髓纤维化患者的异基因造血干细胞移植（allo-HCT）预后：欧洲骨髓移植协会（EBMT）慢性恶性肿瘤工作组的一项研究。

期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-025-02732-w
Sobieralski, Patryk; Czerw, Tomasz; Gras, Luuk; Koster, Linda; Kröger, Nicolaus; Schroeder, Thomas; Friis, Lone; Metafuni, Elisabetta; Passweg, Jakob; Robin, Marie; Stelljes, Matthias; Broers, Annoek E C; Chevallier, Patrice; Zeiser, Robert; Rubio, Marie Therese; Verbeek, Mareike; Yonal-Hindilerden, Ipek; Pastore, Domenico; Zaucha, Jan; Raj, Kavita; Drozd-Sokołowska, Joanna; Battipaglia, Giorgia; Polverelli, Nicola; Hernández-Boluda, Juan Carlos; McLornan, Donal P
肿瘤
肿瘤免疫
细胞生物学
干细胞
发育与干细胞
发表日期：2026
文献求助 收藏

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study

米哚妥林联合强化化疗治疗FLT3突变型急性髓系白血病患者的真实世界应用：一项多中心研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm15020854
Seçilmiş, Sema; Kabukçu Hacıoğlu, Sibel; Hindilerden, Fehmi; Turgut, Burhan; Özatlı, Düzgün; Akgün Çağlıyan, Gülsüm; Baştürk, Abdulkadir; Yüksel Öztürkmen, Aslı; Katırcılar, Yavuz; Namdaroğlu, Sinem; Ünver Koluman, Başak; Sunu, Cenk; Korkmaz, Serdal; Uysal, Ayşe; Bilen, Yusuf; Erkurt, Mehmet Ali; Dal, Mehmet Sinan; Ulaş, Turgay; Altuntaş, Fevzi
白血病
FLT3
发表日期：2026
文献求助 收藏

Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey

鲁索替尼作为挽救疗法治疗类固醇难治性急性和慢性移植物抗宿主病真实世界疗效：一项来自土耳其的多中心回顾性观察研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm15052088
Bakırtaş, Mehmet; Berber, İlhami; Hindilerden, İpek Yönal; Dal, Mehmet Sinan; İzmir Güner, Şebnem; Uysal, Ayşe; Ekinci, Ömer; Aslan Candır, Burcu; Eser, Bülent; Akpınar, Seval; Biçim, Soykan; Yiğenoğlu, Tuğçe Nur; Ulaş, Turgay; Turgut, Burhan; Erkurt, Mehmet Ali; Altuntaş, Fevzi
发表日期：2026
文献求助 收藏

Clinical Impact of Eltrombopag-Associated Iron Chelation in Adults with Immune Thrombocytopenia: A Multicenter Real-World Study

艾曲波帕相关铁螯合治疗对成人免疫性血小板减少症的临床影响：一项多中心真实世界研究

期刊:Mediterranean Journal of Hematology and Infectious Diseases
影响因子:1.5
doi:10.4084/MJHID.2026.027
Yigitbasi, Ahmet; Umit, Elif G; Demirci, Ufuk; Aygun, Guray; Varli, Nese; Aksoy, Elif; Hindilerden, Fehmi; Gulturk, Emine; Davulcu, Eren Arslan; Demir, Ahmet M
血小板
免疫/内分泌
发表日期：2026
文献求助 收藏

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

将 CALR 突变型原发性血小板增多症作为一种独立的疾病实体进行分析，并与 JAK2 V617F 突变型和三阴性患者进行比较。

期刊:Turkish Journal of Medical Sciences
影响因子:1
doi:10.55730/1300-0144.6184
Aydin, Gökhan Sami; Aksoy, Elif; Yönal Hindilerden, İpek; Dağlar Aday, Aynur; Gültürk, Emine; Nalçaci, Meliha; Hindilerden, Fehmi
ALR
CALR
JAK/STAT
血小板
JAK2
发表日期：2026
文献求助 收藏

Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

布伦妥昔单抗单药治疗难治性/复发性经典型霍奇金淋巴瘤的疗效：一项多中心回顾性生存和安全性研究

期刊:
影响因子:
doi:10.1007/s12288-025-02093-w
Bakirtas, Mehmet; Hindilerden, Ipek Yonal; Ulu, Bahar Uncu; Ekinci, Omer; Dogu, Mehmet Hilmi; Aydogdu, Ismet; Berber, Ilhami; Ozatli, Duzgun; Demircioglu, Sinan; Cagliyan, Gulsum Akgun; Namdaroglu, Sinem; Tiryaki, Tarik Onur; Yigenoglu, Tugce Nur; Serin, Istemi; Turgut, Burhan; Albayrak, Murat; Katircilar, Yavuz; Hacıbekiroglu, Tuba; Nalcaci, Meliha; Erkurt, Mehmet Ali; Dal, Mehmet Sinan; Korkmaz, Serdal; Ulas, Turgay; Altuntas, Fevzi
淋巴瘤
发表日期：2026
文献求助 收藏

Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias

抗T淋巴细胞球蛋白联合移植后环磷酰胺25 mg/kg与移植后环磷酰胺50 mg/kg治疗急性白血病患者的疗效比较

期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-025-02564-8
Karakus, Abdullah; Toptas, Tayfur; Dal, Mehmet Sinan; Durdu, Ali; Hatipoglu, Ugur; Kayer, Merve Apaydin; Hindilerden, Ipek Yonal; Tiryaki, Tarik Onur; Iskender, Dicle; Ulu, Bahar Uncu; Yigenoglu, Tugce Nur; Erkurt, Mehmet Ali; Ulas, Turgay; Altuntas, Fevzi
白血病
细胞生物学
发表日期：2025
文献求助 收藏

Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

费城染色体阴性骨髓增生性肿瘤患者的继发性实体瘤：一项多中心研究

期刊:Turkish Journal of Hematology
影响因子:1.3
doi:10.4274/tjh.galenos.2024.2024.0199
Hindilerden, Fehmi; Akay, Özge Nuran; Aksoy, Elif; Dağlar-Aday, Aynur; Gültürk, Emine; Nalçacı, Meliha; Yönal-Hindilerden, İpek
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Analysis of cerebrospinal fluid chimerism after hematopoietic stem cell transplantation: Case report

造血干细胞移植后脑脊液嵌合体分析：病例报告

期刊:
影响因子:
doi:10.1016/j.htct.2024.04.129
Ogret, Yeliz; Tiryaki, Tarik Onur; Cinar, Cigdem Kekik; Hindilerden, Ipek Yonal; Ozluk, Dilek Ozden; Nalcaci, Meliha; Oguz, Fatma Savran
细胞生物学
发育与干细胞
神经科学
干细胞
发表日期：2024
文献求助 收藏